Skip to content
Disclosery

EXANE DERIVATIVES: IBB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on IBB, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,271 IBB shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,271 shares
    Change vs previous 13F +454 shares

    0.09% of the 13F portfolio, value $149,490.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 817 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $106,456.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 817 shares
    Change vs previous 13F -20 shares

    0.03% of the 13F portfolio, value $124,695.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 837 shares
    Change vs previous 13F +60 shares

    0.03% of the 13F portfolio, value $135,331.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 777 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $125,053.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 777 shares
    Change vs previous 13F -48 shares

    0.04% of the 13F portfolio, value $116,990.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 825 shares
    Change vs previous 13F -176 shares

    0.04% of the 13F portfolio, value $124,984.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,001 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $135,547.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).